Boehringer headquarters Ingelheim, Germany Ingelheim, Germany, and Bracknell, United Kingdom SCOVELLA® is the first therapy specifically developed and approved for...
NORTHAMPTON, MA / ACCESS Newswire / August 27, 2026 / When a real patient arrived during a stroke-response training exercise,...
NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Over the past decade, employees at MilliporeSigma, the U.S. and...
Core protections from the Equal Health Care for All Act, which Hall helped conceptualize and advance, are incorporated into the...
accessiBe Recognized for Three-Year Revenue Growth, for the Second Year in a Row, Earning a Place Among the Nation's Most...
Federal award supports development of magnetic robotic navigation technology designed to overcome the physical barriers limiting endovascular navigation and pave...
CALGARY, Alberta, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary,...
The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses,...
ZUG, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The FDA Division of Neurology provided positive feedback supporting a regulatory pathway...
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the...
The #DearAI , powered by Microsoft, built and annotated by people with limb loss and limb differences, is now publicly...
Year-long initiative invites organizations to make meaningful progress towards digital accessibility through support, education and community actionRESTON, Va., July 21,...
Five new courses help caregivers build confidence and practical skills to support neurodiverse/ADHD individualsWALNUT CREEK, Calif., July 15, 2026 /PRNewswire/...
BETHESDA, Md., July 14, 2026 /PRNewswire/ -- Brave Healer Productions proudly announces the release of Brave Families: The Ultimate Guide...
Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained...
CHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding...
MIAMI, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Special Operations Leader to Champion AI-Powered Platform Transforming Veterans' Benefits Access and Confronting the Veteran Suicide CrisisDALLAS, July 1, 2026...
Special Operations Leader to Champion AI-Powered Platform Transforming Veterans' Benefits Access and Confronting the Veteran Suicide CrisisDALLAS, July 1, 2026...
New evaluations support LSAT extended time, additional breaks, and remote testing requests for law school applicants MIAMI, FL / ACCESS...